Super-Refractory Status Epilepticus: Clinical Trials

1 trial for Super-Refractory Status Epilepticus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Super-Refractory Status Epilepticus: new trials by email Literature Review of Super-Refractory Status Epilepticus trials Research Report on Super-Refractory Status Epilepticus

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study With SAGE-547 for Super-Refractory Status Epilepticus
SAGE-547, Placebo - Super-Refractory Status Epilepticus
Phase 3CompletedSupernus Pharmaceuticals, Inc.1322015-06-012025-10-14

Interventions

brexanolone (1)

Sponsors

Supernus Pharmaceuticals, Inc. (1)

Countries

Austria (1)  ·  Canada (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Serbia (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Eric Rosenthal, MD (1)  ·  Mark Wainwright, MD, PhD (1)